PDCD1 and neoplasm: Foxp3‐DTR mice and different tumor models (breast and colorectal cancer) were used to investigate the mechanism, efficacy, and safety of Treg depletion and monoclonal antibodies targeting PD‐1, TIM‐3, and CD137.